Skip Navigation
 

EVENTS

Our meetings provide a national forum for leaders in the field to explore and discuss priorities, challenges, and policy implications in health security.

State of Biopreparedness

The State of Biopreparedness:
Lessons for Leaders, Proposals for Progress


Overview

I would just ask you to think for a minute about the day after a biological attack occurring in Seoul or San Francisco. What is it that we're not doing that we will wish we had been doing that could have prevented that? And what is it that we weren't doing enough of or fast enough or in enough places that could have better prepared us to deal with such an attack?

- Andrew Weber, September 23, 2010

The state of biopreparedness in the U.S. is improving, but many important challenges remain.

Since 2001, federal, state, and local governments and their private sector and NGO partners have collaborated across disciplines to cultivate working relationships and build systems for preparedness, response, and recovery from biological attacks and other public health threats. Experiences with SARS, West Nile virus, hurricanes Katrina and Rita, H5N1 influenza, the 2009 earthquake in Haiti, and the H1N1 pandemic tested U.S. response plans and systems and provided important lessons that have helped strengthen systems and capabilities.

With regard to biodefense specifically, the U.S. has grown stronger in the past 10 years, but there is work that remains to be done in many realms crucial to biopreparedness-including threat assessment, detection and surveillance, countermeasure development and distribution, public health and medical response, and national recovery-all steps in the chain of resilience described by Senator Bob Graham at the conference, The State of Biopreparedness: Lessons from Leaders, Proposals for Progress (Washington, DC; September 23, 2010).

With the support of the Alfred P. Sloan Foundation (conference sponsor), the Center convened this national meeting to provide a forum for thought leaders from the public and private sectors to discuss ongoing challenges and priorities in biopreparedness and identify opportunities for improvement. Read the conference summary report for highlights.

Suggested Background Reading:




Agenda

Watch Videos


Welcome and Opening Remarks

Thomas V. Inglesby, CEO and Director, Center for Biosecurity of UPMC


Biodefense—Strengthening the Chain of Resilience
Senator Bob Graham, Former Chairman, Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism; Co-Founder, The WMD Center


DHS Biodefense Programs and Priorities: Now and in the Years Ahead
Alexander Garza, Assistant Secretary for Health Affairs and Chief Medical Officer, DHS; former Director of Military Programs, ER One Institute, Washington Hospital Center


Contrasting Federal and Local Biodefense Views
Richard Falkenrath, Principal, The Chertoff Group; former Deputy Commissioner for Counterterrorism, NYPD; former Deputy Assistant to the President and Deputy Homeland Security Advisor, The White House


Panel Discussion—How Prepared Is the Nation to Dispense Medical Countermeasures Rapidly to Large Populations?

  • Brooke Courtney, Associate, Center for Biosecurity of UPMC, Moderator
  • Greg Burel, Director, Division of Strategic National Stockpile, U.S. Centers for Disease Control and Prevention (CDC)
  • Michelle Larson, Supervisor, Resource Management and Tracking Unit, Minnesota Department of Health
  • David Starr, Director, Countermeasures and Response Unit, Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene


The United Kingdom Strategy for Biodefense
John Tesh, Deputy Director, Capabilities, UK Civil Contingencies Secretariat


Panel Discussion—Crisis Standards of Care: How Can We Save the Most Lives and Limit Suffering in a Catastrophic Disaster?

  • Eric Toner, Senior Associate, Center for Biosecurity of UPMC, Moderator
  • Dan Hanfling, Special Advisor, Emergency Preparedness and Response, Inova Health System; Clinical Professor, Department of Emergency Medicine, George Washington University
  • James G. Hodge, Jr, Lincoln Professor of Health Law and Ethics, Sandra Day O'Connor College of Law and Fellow, Center for the Study of Law, Science and Technology, Arizona State University


Presentation by Kathleen Sebelius, Secretary, Department of Health and Human Services


Panel Discussion—Preparing to Decontaminate After an Anthrax Attack: What Are the Important Steps Ahead?

  • Crystal Franco, Associate, Center for Biosecurity of UPMC, Moderator
  • Peter Jutro, Deputy Director for Science and Policy, National Homeland Security Research Center, Environmental Protection Agency
  • Joseph Donovan, Senior Vice President, Beacon Capital Partners; Building Owners and Managers (BOMA) National Preparedness Committee


DoD Biodefense Challenges and Accomplishments
Andrew C. Weber, Assistant to Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, DoD


White House Views on Biopreparedness
Richard Hatchett, Director for Medical Preparedness Policy, White House National Security Staff (off the record)


Concluding Remarks
Thomas V. Inglesby, CEO and Director, Center for Biosecurity of UPMC




Speakers
 

Greg Burel
Greg Burel
Director, Division of Strategic National Stockpile, U.S. Centers for Disease Control and Prevention (CDC)
 
Anita Cicero
Anita Cicero, JD
COO and Deputy Director, Center for Biosecurity of UPMC
 
Brooke Courtney
Brooke Courtney, JD, MPH
Associate, Center for Biosecurity of UPMC
 
Joseph Donovan
Joseph Donovan
Senior Vice President, Beacon Capital Partners; Building Owners and Managers (BOMA) National Preparedness Committee
 
Richard Falkenrath
Richard Falkenrath, PhD
Principal, The Chertoff Group; former Deputy Commissioner for Counterterrorism, New York City Police Department; former Deputy Assistant to the President and Deputy Homeland Security Advisor, The White House
 
Crystal Franco
Crystal Franco, MPH
Associate, Center for Biosecurity of UPMC, Moderator
 
Alexander Garza
Alexander Garza, MD, MPH
Assistant Secretary for Health Affairs and Chief Medical Officer, DHS; former Director of Military Programs, ER One Institute, Washington Hospital Center
 
Senator Bob Graham
Senator Bob Graham
Former Chairman, Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism; Co-Founder, The WMD Center
 
Dan Hanfling
Dan Hanfling, MD
Special Advisor, Emergency Preparedness and Response, Inova Health System; Clinical Professor, Department of Emergency Medicine, George Washington University
 
Richard Hatchett
Richard Hatchett, MD
Director for Medical Preparedness Policy, White House National Security Staff
 
James G. Hodge Jr.
James G. Hodge Jr., JD, LLM
Lincoln Professor of Health Law and Ethics, Sandra Day O'Connor College of Law and Fellow, Center for the Study of Law, Science and Technology, Arizona State University
 
Tom Inglesby
Thomas Inglesby, MD
Chief Executive Officer and Director, Center for Biosecurity of UPMC
 
Peter Jutro
Peter Jutro, PhD
Deputy Director for Science and Policy, National Homeland Security Research Center, Environmental Protection Agency
 
Michelle Larson
Michelle Larson, MPA
Supervisor, Resource Management and Tracking Unit, Minnesota Department of Health
 
Kathleen Sebelius
Kathleen Sebelius, MPA
Secretary, Department of Health and Human Services
 
David Starr
David Starr, MIA
Director, Countermeasures and Response Unit, Office of Emergency Preparedness and Response, New York City Department of Health and Mental Hygiene
 
John Tesh
John Tesh
Deputy Director, Capabilities, UK Civil Contingencies Secretariat
 
Eric Toner
Eric Toner, MD
Senior Associate, Center for Biosecurity of UPMC, Moderator
 
Andrew C. Weber
Andrew C. Weber, MS
Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs, DoD
 



Attendees

  • Sandra Alcala
  • Amesh Adalja, Center for Biosecurity of UPMC
  • Jennifer Bryning Alton, Bavarian Nordic
  • Phyllis Arthur, Biotechnology Industry Organization
  • Micah Baker, Camber/JPEO
  • Dan Barnett, Johns Hopkins Bloomberg School of Public Health
  • Noah Bartolucci, U.S. Department of Homeland Security
  • Georges Benjamin, American Public Health Association
  • Kavita Berger, American Assn. for the Advancement of Science
  • Diane Berry, U.S. Department of Homeland Security
  • Luciana Borio, Food and Drug Administration
  • Nidhi Bouri, Center for Biosecurity of UPMC
  • Melissa Bowie, BIO
  • Andrew Bowman, Drinker Biddle & Reath LLP
  • Kathryn Brinsfield, U.S. Department of Homeland Security
  • Mallory Bulman, U.S. Government Accountability Office
  • Gregory Burel, CDC
  • Ellen Carlin, House Committee on Homeland Security
  • Anita Cicero, Center for Biosecurity of UPMC
  • John Clizbe, Atlantic BB
  • Karen Coffman, MITRE
  • Kelly Stefano Cole, University of Pittsburgh
  • Francesca Cook, PharmAthene
  • Michelle Cooper, U.S. Government Accountability Office
  • Jerome Cordts, MITRE
  • Kelly Stefano Cole
  • Bernard Courtney, The Tauri Group
  • Brooke Courtney, Center for Biosecurity of UPMC
  • David Cullin, ICx Technologies
  • Lee Daugherty, Johns Hopkins School of Medicine
  • Shana Deitch, U.S. Government Accountability Office
  • Raphael Della Ratta, Partnership for a Global Security
  • Ulyana Desiderio, American Society of Hematology
  • Molly D'Esopo, Center for Biosecurity of UPMC
  • Diane DiEuliis, OSTP
  • Gary Disbrow, U.S. Dept. of Health & Human Services
  • Dee Ann Divis, Washington Examiner
  • Joe Donovan, Beacon Capital
  • Bonnie Doty, U.S. Government Accountability Office
  • Joshua Easton, UMB - Center for Health and Homeland Security
  • Joanna Engstrom-Brown, Center for Biosecurity of UPMC
  • Gerald Epstein, American Assn. for the Advancement of Science
  • Richard Falkenrath, The Chertoff Group
  • Aaron Firoved
  • Julie Fischer, Stimson Center
  • Crystal Franco, Center for Biosecurity of UPMC
  • Arthur Friedlander, USAMRIID
  • Andrew Garrett, National Disaster Medical System
  • Alexander Garza, U.S. Department of Homeland Security
  • Joel Gaydos, U.S. Department of Defense Armed Forces Health Surveillance Center
  • Kathryn Godfrey, U.S. Government Accountability Office
  • Frank Gottron, Congressional Research Service
  • Ian Grant, OSD
  • Kelsey Gregg, Federation of American Scientists
  • Michael Gresalfi, DHS/FEMA
  • Louise Gresham, NTI
  • Gigi Kwik Gronvall, Center for Biosecurity of UPMC
  • Jonathan Gross, National Center for Medical Intelligence
  • Elin Gursky, U.S. Dept. of Health & Human Services
  • James Guyton, PRTM Management Consultants, LLC
  • Dan Hanfling, Inova Health System
  • Mary Beth Hansen, Center for Biosecurity of UPMC
  • Cynthia Hansen, U.S. Dept. of Health & Human Services
  • Richard Hatchett, National Security Staff
  • Herb Hecht, Emergent BioSolutions
  • Lisa Hensley, USAMRIID
  • Alice Hill, U.S. Department of Homeland Security
  • Penny Hitchcock, Tauri Group
  • James Hodge, ASU
  • Erin Hoffman, U.S. Department of Homeland Security
  • Dennis Hruby, SIGA
  • Adam Hutter, U.S. Dept. of Health & Human Services
  • Thomas V. Inglesby, Center for Biosecurity of UPMC
  • Audrey Jackson, Infectious Diseases Society of America
  • Peter Jahrling, National Institutes of Health
  • James James, American Medical Association
  • Til Jolly, DHS/FEMA
  • Peter Jutro, U.S. Environmental Protection Agency
  • Brian Kamoie, The White House
  • Peter Katona, UCLA
  • Rebecca Katz, U.S. Department of State
  • Arthur Kellermann, RAND
  • Lynne Kidder, Center for Excellence in Disaster Management/Humanitarian Assistance
  • Andrew Kim, DTRA
  • Randall Kincaid, DTRA
  • Ann Knebel, HHS
  • John Koerner, HHS/ASPR
  • Matt Korade, Congressional Quarterly
  • George Korch, ASPR/HHS
  • Akhila Kosaraju, SIGA Technologies
  • Gerald Kovacs, HHS/ASPR/BARDA
  • Mark Kovler, Kovler Foundation
  • Deborah Kramer, Joint Program Executive Office for Chemical and Biological Defense
  • Nicole Kunko, House Appropriations Committee
  • Clarence Lam, Johns Hopkins Bloomberg School of Public Health
  • Michael Langford, BNBI
  • Randy Larsen, WMD Center
  • Michelle Larson, Minnesota Dept. of Health
  • Mark Lauda, U.S. Dept. of Health & Human Services
  • Matthew Lawlor, HHS/ASPR/BARDA
  • Deborah Levy, CDC
  • Dara Lieberman, Trust for America's Health
  • Tanna Liggins, Center for Biosecurity of UPMC
  • Davia Lilly, Center for Biosecurity of UPMC
  • Carol Linden, U.S. Dept. of Health & Human Services
  • Sarah Lister, Congressional Research Service
  • Dan Lucey, Georgetown Department of Microbiology and Immunology
  • Monique Mansoura, DHHS/ASPR/OPP
  • Craig Martinez, Senate HELP Committee
  • Martin Matishak, Global Security Newswire
  • Bruce Miller, Systems Planning and Analysis, Inc
  • Linda Millis, Office of the Director of National Intelligence
  • Ryan Morhard, Center for Biosecurity of UPMC
  • Erin Mullen, Rx Response
  • Jessica Nagasako, HSGAC
  • Ann Norwood, Center for Biosecurity of UPMC
  • Jennifer Nuzzo, Center for Biosecurity of UPMC
  • Paula Olsiewski, Alfred P. Sloan Foundation
  • Sonia Ben Ouagrham-Gormley, George Mason University
  • Tracy Parker, U.S. Department of Homeland Security
  • Robert Pestronk, NACCHO
  • Thomas Phan, (HDMA) Healthcare Distribution Management Association
  • Sally Phillips, AHRQ
  • Jude Plessas, U.S. Postal Service
  • Andy Pope, National Academy Sciences
  • Margaret Potter, University of Pittsburgh
  • Beth Rada, XOMA
  • Lewis Radonovich, Department of Veterans Affairs
  • Kunal Rambhia, Center for Biosecurity of UPMC
  • William Raub
  • Irwin Redlener, Columbia Univ. National Center for Disaster Preparedness
  • Corinne Ringholz, ANSER
  • Al Romanosky, Maryland DHMH
  • Deborah Rosenblum, NTI
  • Philip Russell
  • David Schneider, U.S. Government Accountability Office
  • Monica Schoch-Spana, Center for Biosecurity of UPMC
  • Roslyne Schulman, American Hospital Association
  • Kathleen Sebelius, U.S. Dept. of Health & Human Services
  • Fred Selck, Center for Biosecurity of UPMC
  • Yuliya Seldina
  • Tara Kirk Sell, Center for Biosecurity of UPMC
  • Sikha Singh, APHL
  • Brad Smith, Center for Biosecurity of UPMC
  • David Starr, New York City Department of Health & Mental Hygiene
  • Earl Stoddard, University of Maryland Center for Health and Homeland Security
  • Ashely Stover, Office of Robert P. Casey, Jr.
  • Clare Stroud, Institute of Medicine
  • Kate Summers, U.S. Senate Sergeant at Arms
  • John Tesh, UK Civil Contingencies Secretariat
  • Eric Toner, Center for Biosecurity of UPMC
  • Nicholas Townsend, Arnold & Porter LLP
  • Tim Trevan, International Council for Life Sciences
  • Price Tyson, Center for Biosecurity of UPMC
  • Sarah Veale, U.S. Government Accountability Office
  • Jo Velardo, Homeland Security Studies and Analysis Institute
  • John Wade, Battelle
  • Richard Waldhorn, Center for Biosecurity of UPMC
  • Matthew Watson, Center for Biosecurity of UPMC
  • Andrew Weber, U.S. Department of Defense
  • Anna Weinstein, Biotechnology Industry Organization
  • Mark Weitekamp, ANSER
  • Gregory Whitten, OSD
  • Andrew Willman, National Association of City and County Health Officials
  • Sam Wollner, Center for Biosecurity of UPMC
  • Roger Yee, Senate Committee on Homeland Security and Governmental Affairs